Clinical Trials Directory

Trials / Completed

CompletedNCT04248803

Evaluation of Gluma Desensitizer in Post-treatment Sensitivity in Posterior Composite

Efficacy of Gluma Desensitizer in Controlling the Immediate Post-treatment Sensitivity in Etch-and-rinse and Self-etch Adhesive Bonded Occlusal Composite Restorations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
570 (actual)
Sponsor
Tamil Nadu Dr.M.G.R.Medical University · Academic / Other
Sex
All
Age
15 Years – 70 Years
Healthy volunteers
Accepted

Summary

To evaluate the effect of Gluma desensitizer in controlling immediate post-treatment sensitivity in posterior occlusal composite restorations.

Detailed description

The primary objective of this study is to observe the effect of gluma desensitizer application in controlling the post-treatment sensitivity in posterior occlusal composite restoration in molar teeth using 2 adhesive bonding strategies. The secondary objective is to evaluate the difference in the post-treatment sensitivity on application of Gluma desensitizer either prior to or after acid etching. The different adhesive gluma desensitizer application groups are randomly divided into 6 groups, 1. Total etch control group (No gluma desensitizer application) 2. Total etch group Gluma (Kulzer GmbH, Germany) desensitizer application prior to acid etching 3. Total etch group Gluma (Kulzer GmbH, Germany) desensitizer application after acid etching 4. Self etch control group (No gluma desensitizer application) 5. Self etch group Gluma (Kulzer GmbH, Germany) desensitizer application prior to acid etching 6. Self etch group Gluma (Kulzer GmbH, Germany) desensitizer application after acid etching

Conditions

Interventions

TypeNameDescription
OTHERGLUMA (Kulzer GmbH, Germany) desensitizing agentGLUMA desensitizer is used to reduce tooth sensitivity

Timeline

Start date
2020-02-06
Primary completion
2025-02-20
Completion
2025-02-20
First posted
2020-01-30
Last updated
2025-10-20
Results posted
2025-10-20

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04248803. Inclusion in this directory is not an endorsement.